title: CD27 expression on lymphocyte and sCD27 levels in children with asthma.
abstract: BACKGROUND
  CD27, a lymphocyte specific member of the Tumour Necrosis Factor- Receptor (TNF-R) family is expressed on the majority of peripheral blood T cells. Activation of T cells via TCR/CD3 induces high CD27 surface expression and release of a soluble form (sCD27) of the molecule. sCD27 level increases in patients suffering from a variety of chronic inflammatory diseases. In the present study we aimed to measure both the serum sCD27 levels and CD27 expression on T cells in asthmatic patients, to evaluate the state of this molecule in allergic inflammation.
  
  
  METHODS
  Forty-three patients with asthma were included in to the study. CD27 molecule expression and soluble form of this molecule were analysed in atopic asthmatic (n:17) and non-atopic asthmatic (n:13) patients receiving inhaled corticosteroid treatment, in asthmatic patients whose treatment ceased at least for 6 months (n:13) and healthy control subjects (n:14).
  
  
  RESULTS
  There were no differences in the expression of CD27 molecule on peripheral blood lymphocyte nor in its soluble form sCD27 levels in sera between the atopic asthmatic and non-atopic asthmatic patients receiving ICS treatment, treatment free asthmatic patients and healthy control subjects.
  
  
  CONCLUSIONS
  Neither the soluble form of CD27 nor its expression on T cells seem to be a reliable marker of atopic or non-atopic asthmatic inflammation.
authors.affiliation: Department of Pediatric Immunology and Allergy, Ankara University School of Medicine, Turkey. gunselibozdogan@yahoo.com
authors.forename: G
authors.initials: G
authors.lastname: Bozdogan
authors.forename: F
authors.initials: F
authors.lastname: Dogu
authors.forename: D
authors.initials: D
authors.lastname: Güloglu
authors.forename: M
authors.initials: M
authors.lastname: Yuksek
authors.forename: C
authors.initials: C
authors.lastname: Aytekin
authors.forename: A
authors.initials: A
authors.lastname: Ikinciogullari
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D001249:Asthma / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology; D002648:Child; D002675:Child, Preschool; D005260:Female; D005786:Gene Expression Regulation / Q000276:immunology; D006801:Humans; D016130:Immunophenotyping; D008213:Lymphocyte Activation; D008297:Male; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7 / Q000235:genetics / Q000378:metabolism*; D028761:Withholding Treatment
chemical_list: D000305:Adrenal Cortex Hormones; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7